Evidence map›Paper›PMID 42365543›Full record

ArticleClinical journal of gastroenterology2026

A case of small pancreatic neuroendocrine tumor of less than 10 mm showing metastasis to multiple organs.

Tomoki Ogata, Kazuo Hara, Nozomi Okuno, Nobumasa Mizuno, Shin Haba, Takamichi Kuwahara, Hiroki Koda, Shimpei Matsumoto, Keigo Oshiro, Waki Hosoda

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomoki OgataDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Kazuo HaraDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan. khara@aichi-cc.jp.ORCID http://orcid.org/0000-0002-4699-6136
Nozomi OkunoDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Nobumasa MizunoDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Shin HabaDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Takamichi KuwaharaDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Hiroki KodaDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Shimpei MatsumotoDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Keigo OshiroDepartment of Gastroenterology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.
Waki HosodaDepartment of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small non-functioning pancreatic neuroendocrine tumors (pNETs) measuring under 10 mm are considered eligible for observation and follow-up, although a minority of small NETs may exhibit show an aggressive behavior. We report a case of small G2-NET that was surgically removed and later developed metastatic recurrence in multiple organs. The patient, a woman in her sixties with a pancreatic body cyst, had been under follow-up for more than a decade. Several years later, a hypoechoic area appeared in the pancreatic body. Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) was performed twice; however, a definitive diagnosis was not obtained. Subsequent EUS revealed extension of the lesion into the main pancreatic duct, which was diagnosed as a pancreatic body tumor with intraductal extension. Distal pancreatectomy was performed, and histology revealed a small G2-NET, measuring 8 × 7 mm in diameter. Multiple metastatic tumors were detected 4.5 years after surgery, and the patient is currently undergoing treatment with everolimus and lanreotide. This case supports the viewpoint that small G2-NETs, even those measuring less than 10 mm, may have a risk of metastasis, highlighting the need for careful follow-up and appropriate therapeutic interventions.

Indexed as

Neuroendocrine TumorsPancreatic NeoplasmsEndoscopic Ultrasound-Guided Fine Needle AspirationFemaleHumansMiddle AgedPancreatectomyNeuroendocrine tumor Grade 2 < 10 mmNeuroendocrine tumor with intraductal extensionPerflubutane contrast

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.